338
Views
19
CrossRef citations to date
0
Altmetric
Research Article

Effects of omalizumab on eosinophil cationic peptide, 25-hydroxyvitamin-D, IL-1β and sCD200 in cases of Samter's syndrome: 36 months follow-up

, , &
Pages 524-527 | Received 07 Apr 2013, Accepted 01 Jun 2013, Published online: 10 Jul 2013

References

  • Zeitz HJ. Bronchial asthma, nasal polyps, and aspirin sensitivity: Samter's syndrome. Clin Chest Med 1988;9:567–576
  • Shen J, Peterson M, Mafee M, Nguyen QT. Aural polyps in Samter's triad: case report and literature review. Otol Neurotol 2012;33:774–778
  • Onerci M, Elsurer C, Guzel EE, Dagdeviren A. Distribution of inflammatory cells, adhesion molecules, intermediate filaments, and chemokine receptors in subgroups of nasal polyp patients. Am J Rhinol Allergy 2011;25:176–180
  • Amar YG, Frenkiel S, Sobol SE. Outcome analysis of endoscopic sinus surgery for chronic sinusitis in patients having Samter's triad. J Otolaryngol 2000;29:7–12
  • Mendelsohn D, Jeremic G, Wright ED, Rotenberg BW. Revision rates after endoscopic sinus surgery: a recurrence analysis. Ann Otol Rhinol Laryngol 2011;120:162–166
  • Kim JE, Kountakis SE. The prevalence of Samter's triad in patients undergoing functional endoscopic sinus surgery. Ear Nose Throat J 2007;86:396–399
  • Chang TW, Shiung YY. Anti IgE as a mast cell stabilizing therapeutic agent. J Allergy Clin Immunol 2006;117:1203–1212
  • Chang TW. The pharmacological basis of anti-IgE therapy. Nat Biotechnol 2000;18:157–162
  • Noga O, Hanf G, Brachmann I, et al. Effect of omalizumab treatment on peripheral eosinophil and T-lymphocyte function in patients with allergic asthma. J Allergy Clin Immunol 2006;117:1493–1499
  • Yalcin AD, Bisgin A, Gorczynski RM. IL-8, IL10, TGF-β and GCSF levels were increased in severe persistent allergic asthma patients with the anti-IgE treatment. Mediators Inflammation 2012;2012: Article ID 720976. doi:10.1155/2012/720976
  • Yalcin AD, Gumuslu S, Parlak GE, et al. Systemic levels of ceruloplasmin oxidase activity in allergic asthma and allergic rhinitis. Immunopharmacol Immunotoxicol 2012;34:1047--1053
  • Yalcin AD, Gorczynski RM, Parlak GE, et al. Total antioxidant capacity, hydrogen peroxide, malondialdehyde and total nitric oxide concentrations in patients with severe persistent allergic asthma: its relation to omalizumab treatment. Clin Lab 2012;58:89–96
  • Awad OG, Lee JH, Fasano MB, Graham SM. Sinonasal outcomes after endoscopic sinus surgery in asthmatic patients with nasal polyps: a difference between aspirin-tolerant and aspirin-induced asthma? Laryngoscope 2008;118:1282–1286
  • Yalcin AD, Gorczynski RM, Cilli A, Straus L. Omalizumab (anti-IgE) therapy increases blood glucose levels in severe persistent allergic asthma patients with diabetes mellitus: 18 months follow-up. Clin Lab, in press
  • Global Initiative for Asthma: GINA Report, Global Strategy for Asthma Management and Prevention – updated 2006. 2006. Available from: www.ginasthma.org
  • Roca J, Sanchis J, Agusti-Vidal A. Spirometric reference values from a Mediterranean population. Clin Respir Physiol 1986;22:217–224
  • Kim CK. Eosinophil-derived neurotoxin: a novel biomarker for diagnosis and monitoring of asthma. Korean J Pediatr 2013;56:8–12
  • Scott S, Currie J, Albert P, et al. Risk of misdiagnosis, health-related quality of life, and BMI in patients who are overweight with doctor-diagnosed asthma quality of life in obese patients with asthma. Chest 2012;141:616–624
  • Yalcin AD, Karakas AA, Soykam G, et al. A case of toxic epidermal necrolysis with diverse etiologies: successful treatment with intravenous immunoglobulin and pulse prednisolone and effects on sTRAIL and sCD200 levels. Clin Lab 2013;59:681--685
  • Gorczynski RM. CD200:CD200R-mediated regulation of immunity. ISRN Immunol 2012;2012: Article ID 682168. doi:10.5402/2012/682168
  • Norton R, O'Connell MA. Vitamin D: potential in the prevention and treatment of lung cancer. Anticancer Res 2012;32:211–221
  • Korn S, Hübner M, Jung M, et al. Severe and uncontrolled adult asthma is associated with vitamin D insufficiency and deficiency. Respir Res 2013;14:25 doi: 10.1186/1465-9921-14-25.
  • Krause K, Metz M, Makris M, et al. The role of interleukin-1 in allergy-related disorders. Curr Opin Allergy Clin Immunol 2012;12:477–484
  • Gevaert P, Calus L, Van Zele T. Omalizumab is effective in allergic and nonallergic patients with nasal polyps and asthma. J Allergy Clin Immunol 2013;131:110–116
  • Scadding GK, Gray P, Belvisi MG, Mitchell JA. High levels of nitric oxide synthase activity are associated with nasal polyp tissue from aspirin-sensitive asthmatics. Acta Otolaryngol 2002;122:302–305

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.